Suppr超能文献

晚期可切除黑色素瘤的新辅助治疗

Neoadjuvant Treatments for Advanced Resectable Melanoma.

作者信息

Liu Jessica Y, Lowe Michael

机构信息

Department of Surgery, Emory University, Atlanta, Georgia.

Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University, Atlanta, Georgia.

出版信息

J Surg Oncol. 2019 Jan;119(2):216-221. doi: 10.1002/jso.25352. Epub 2018 Dec 27.

Abstract

Neoadjuvant therapy has demonstrated promise as a treatment modality in resectable advanced-stage melanoma. Treatment has evolved beyond chemotherapy, with the utilization of biochemotherapy, immunotherapy, and targeted therapy in the neoadjuvant setting. These therapies have shown better progression-free survival and melanoma-specific survival when compared with patients that proceed directly to surgery. Ongoing clinical trials will continue to propel research forward to improve the available options for patients with resectable advanced regional disease.

摘要

新辅助治疗已被证明有望成为可切除晚期黑色素瘤的一种治疗方式。治疗方法已从化疗发展而来,在新辅助治疗中采用了生物化疗、免疫治疗和靶向治疗。与直接进行手术的患者相比,这些治疗方法显示出更好的无进展生存期和黑色素瘤特异性生存期。正在进行的临床试验将继续推动研究向前发展,以改善可切除晚期区域疾病患者的现有治疗选择。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验